Skip to main content

Kodiak AI, Inc.

For the period ended Dec 31, 2025. Filed Mar 11, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 11, 2026

KDK$1.21-16.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(In thousands)

Year Ended December 31,
202520242023
Operating activities:
Net loss$(585,525)$(69,459)$(56,945)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization3,2484,6164,114
Stock-based compensation19,0825,5505,399
Non-cash lease expense1,8531,8322,164
Accretion of discount on marketable securities(480)—(909)
Transaction costs allocated to common stock warrants3,223——
Change in fair value of second lien loans24,387——
Change in fair value of simple agreements for future equity190,0754,109—
Change in fair value of redeemable convertible preferred stock warrant liabilities7,272(426)(126)
Change in fair value of common stock warrants35,018——
Loss on issuance of equity instruments210,722——
Non-cash interest expense795402788
Loss on disposal of property and equipment265——
Changes in operating assets and liabilities:
Accounts receivable401(1,044)9
Prepaid expenses and other current assets(2,180)645(484)
Other assets(105)276(276)
Accounts payable(717)(811)558
Accrued expenses and other current liabilities(407)5,1023,833
Operating lease liabilities(1,861)(1,796)(2,222)
Other liabilities49243255
Net cash used in operating activities(94,442)(50,961)(43,842)
Investing activities:
Proceeds from maturities of marketable securities——51,000
Purchases of marketable securities(69,406)—(30,452)
Purchases of property and equipment(22,026)(3,192)(3,270)
Payment of deposits—(20)—
Net cash (used in) provided by investing activities(91,432)(3,212)17,278
Financing activities:
Proceeds from the issuance of debt, net of issuance costs29,662—3,671
Repayment of debt(33,381)(2,238)(1,934)
Proceeds from issuance of second lien loans43,865——
Proceeds from issuance of simple agreements for future equity23,66045,19210,000
Proceeds from issuance of Series A cumulative redeemable convertible preferred stock145,000——
Proceeds from the reverse recapitalization, net of transaction costs26,239——
Proceeds from exercise of stock options1,422172292
Proceeds from exercise of common stock warrants77——
Payments for deferred offering costs(16,618)——
Net cash provided by financing activities219,92643,12612,029
Net change in cash and cash equivalents and restricted cash34,052(11,047)(14,535)
Cash and cash equivalents and restricted cash at beginning of period18,15929,20643,741
Cash and cash equivalents and restricted cash at end of period$52,211$18,159$29,206
Components of cash and restricted cash at period end:
Cash and cash equivalents$50,761$16,709$27,756
Restricted cash1,4501,4501,450
Total cash and cash equivalents and restricted cash$52,211$18,159$29,206
Supplemental disclosure of cash activities:
Cash paid for interest$3,303$4,561$4,606
Cash paid for income taxes$—$3$5
Supplemental disclosure of non-cash activities:
Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities$1,360$118$—
Operating lease right-of-use asset obtained in exchange for operating lease liability upon modification of operating lease$—$1,881$2,388
Operating lease right-of-use asset obtained in exchange for operating lease liability upon new operating lease$—$1,146$—
Proceeds from exercise of stock options included in prepaid and other current assets$12$—$14
Proceeds from exercise of common stock warrants included in prepaid and other current assets$9$—$—
Conversion of simple agreements for future equity into common stock in connection with reverse recapitalization$263,036$—$—
Conversion of redeemable preferred stock into common stock in connection with reverse recapitalization$170,648$—$—
Conversion of second lien loans into common stock in connection with reverse recapitalization$67,379$—$—
Settlement of transaction costs in common stock in connection with reverse recapitalization$12,500$—$—
Exchange of simple agreements for future equity for second lien loan$10,000$—$—
Net exercise of warrants in connection with reverse recapitalization$8,891$—$—
Issuance of non-redemption common stock in connection with reverse recapitalization$3,220$—$—
Liabilities assumed from reverse recapitalization$31$—$—
Issuance of common stock in connection with a debt agreement$499$—$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.